Victor Chang Cardiac Research Institute, Darlinghurst, NSW, 2010, Australia.
St Vincent's Clinical School, University of New South Wales, Darlinghurst, NSW, 2010, Australia.
Epigenetics Chromatin. 2019 Jun 13;12(1):36. doi: 10.1186/s13072-019-0273-x.
DamID, in which a protein of interest is fused to Dam methylase, enables mapping of protein-DNA binding through readout of adenine methylation in genomic DNA. DamID offers a compelling alternative to chromatin immunoprecipitation sequencing (ChIP-Seq), particularly in cases where cell number or antibody availability is limiting. This comes at a cost, however, of high non-specific signal and a lowered spatial resolution of several kb, limiting its application to transcription factor-DNA binding. Here we show that mutations in Dam, when fused to the transcription factor Tcf7l2, greatly reduce non-specific methylation. Combined with a simplified DamID sequencing protocol, we find that these Dam mutants allow for accurate detection of transcription factor binding at a sensitivity and spatial resolution closely matching that seen in ChIP-seq.
DamID 技术将感兴趣的蛋白质与 Dam 甲基酶融合,通过读取基因组 DNA 中的腺嘌呤甲基化,实现蛋白质-DNA 结合的定位。DamID 技术为染色质免疫沉淀测序(ChIP-Seq)提供了一种极具吸引力的替代方法,特别是在细胞数量或抗体可用性有限的情况下。然而,这种方法也存在一些缺点,如非特异性信号高和空间分辨率降低几个 kb,限制了其在转录因子-DNA 结合研究中的应用。在这里,我们表明,当 Dam 突变与转录因子 Tcf7l2 融合时,非特异性甲基化会大大降低。结合简化的 DamID 测序方案,我们发现这些 Dam 突变体能够准确检测转录因子的结合,其灵敏度和空间分辨率与 ChIP-seq 非常匹配。